TY - JOUR
T1 - TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients
AU - Magi-Galluzzi, Cristina
AU - Tsusuki, Toyonori
AU - Elson, Paul
AU - Simmerman, Kelly
AU - Lafargue, Chris
AU - Esgueva, Raquel
AU - Klein, Eric
AU - Rubin, Mark A.
AU - Zhou, Ming
PY - 2011/4
Y1 - 2011/4
N2 - Background Prostate cancer (PCa) exhibits significant differences in prevalence and mortality among different ethnic groups. The underlying genetics is not well understood. TMPRSS2-ERG fusion is a common recurrent chromosomal aberration in PCa and is however not studied among different ethnic groups. We examined the prevalence and class of TMPRSS2-ERG gene fusion in PCa from Caucasian, African-American, and Japanese patients. MATERIALS AND Methods A tissue microarray of PCa from 42 Caucasians, 64 African-Americans, and 44 Japanese patients who underwent radical prostatectomies (RP) was studied for TMPRSS2-ERG fusion using a multicolor interphase fluorescence in situ hybridization assay for ERG gene break-apart. Results TMPRSS2-ERG gene fusion was present in 50% (21/42) of Caucasians, 31.3% (20/64) of African-Americans, and 15.9% (7/44) of Japanese (P = 0.003). The gene fusion through translocation, deletion, or both occurred in 61.9% (13/21), 38.1% (8/21), and 0% (0/21) in Caucasians, 20% (4/20), 60% (12/20), and 20% (4/20) in African-Americans, and 71.4% (5/7), 28.6% (2/7), and 0% (0/7) in Japanese patients (P = 0.02). A multivariate analysis demonstrated that TMPRSS2-ERG gene fusion correlated with the ethnicity (P = 0.03), marginally correlated with the pathologic stage (P = 0.06), but not other clinicopathologic parameters, including age, preoperative PSA levels, and Gleason score. ConclusionS The prevalence and class of TMPRSS2-ERG are significantly different in PCa of Caucasian, African-American, and Japanese patients. Future studies of the molecular pathways implicated in TMPRSS2-ERG gene fusion may shed light on the disparity in prevalence and mortality of PCa among different ethnic groups and help design better prevention and treatment strategies. Prostate 77:489-497, 2011.
AB - Background Prostate cancer (PCa) exhibits significant differences in prevalence and mortality among different ethnic groups. The underlying genetics is not well understood. TMPRSS2-ERG fusion is a common recurrent chromosomal aberration in PCa and is however not studied among different ethnic groups. We examined the prevalence and class of TMPRSS2-ERG gene fusion in PCa from Caucasian, African-American, and Japanese patients. MATERIALS AND Methods A tissue microarray of PCa from 42 Caucasians, 64 African-Americans, and 44 Japanese patients who underwent radical prostatectomies (RP) was studied for TMPRSS2-ERG fusion using a multicolor interphase fluorescence in situ hybridization assay for ERG gene break-apart. Results TMPRSS2-ERG gene fusion was present in 50% (21/42) of Caucasians, 31.3% (20/64) of African-Americans, and 15.9% (7/44) of Japanese (P = 0.003). The gene fusion through translocation, deletion, or both occurred in 61.9% (13/21), 38.1% (8/21), and 0% (0/21) in Caucasians, 20% (4/20), 60% (12/20), and 20% (4/20) in African-Americans, and 71.4% (5/7), 28.6% (2/7), and 0% (0/7) in Japanese patients (P = 0.02). A multivariate analysis demonstrated that TMPRSS2-ERG gene fusion correlated with the ethnicity (P = 0.03), marginally correlated with the pathologic stage (P = 0.06), but not other clinicopathologic parameters, including age, preoperative PSA levels, and Gleason score. ConclusionS The prevalence and class of TMPRSS2-ERG are significantly different in PCa of Caucasian, African-American, and Japanese patients. Future studies of the molecular pathways implicated in TMPRSS2-ERG gene fusion may shed light on the disparity in prevalence and mortality of PCa among different ethnic groups and help design better prevention and treatment strategies. Prostate 77:489-497, 2011.
KW - TMPRSS2-ERG gene fusion
KW - ethnicity
KW - prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=79951548592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951548592&partnerID=8YFLogxK
U2 - 10.1002/pros.21265
DO - 10.1002/pros.21265
M3 - Article
C2 - 20878952
AN - SCOPUS:79951548592
SN - 0270-4137
VL - 71
SP - 489
EP - 497
JO - Prostate
JF - Prostate
IS - 5
ER -